Opus Genetics Stock Target Price and Analyst Consensus
| IRD Stock | 2.31 0.19 7.60% |
The current analyst and expert consensus on Opus Genetics is Strong Buy, with 2 strong buy opinions. The current projected Opus Genetics target price consensus is 7.73 with 3 analyst opinions. Check out Macroaxis Advice on Opus Genetics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Opus Stock refer to our How to Trade Opus Stock guide.The most common way Opus Genetics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Opus Genetics executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Opus Genetics. We encourage you to use your own analysis of Opus Genetics to validate this buy or sell advice. Opus Genetics buy-or-sell recommendation module provides average expert sentiment on the projected Opus Genetics target price to derive its highest and lowest estimates based on projected price volatility of 4.2426.
Lowest Forecast 7.03 | Highest Forecast 8.58 | Target Price 7.73 |
It's important to approach Opus Genetics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Opus Genetics Target Price Consensus
Opus target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Opus Genetics' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 3 | Strong Buy |
Most Opus analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Opus stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Opus Genetics, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationOpus Genetics Target Price Projection
Opus Genetics' current and average target prices are 2.31 and 7.73, respectively. The current price of Opus Genetics is the price at which Opus Genetics is currently trading. On the other hand, Opus Genetics' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Opus Genetics Market Quote on 31st of January 2026
Target Price
Analyst Consensus On Opus Genetics Target Price
Opus Genetics Analyst Ratings
Opus Genetics' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Opus Genetics stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Opus Genetics' financials, market performance, and future outlook by experienced professionals. Opus Genetics' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Opus Genetics price targets
Opus Genetics' stock target price is an estimate of its future price, usually made by analysts. Using Opus Genetics' target price to determine if it is a suitable investment can be done through the following steps:- Look at Opus Genetics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Opus Genetics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Opus Genetics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Opus Genetics is a key component of Opus Genetics valuation and have some predictive power on the future returns of a Opus Genetics.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Warren Buffett Holdings Invested few shares | |
 | Momentum Invested over 20 shares | |
 | Impulse Invested over 200 shares | |
 | Manufacturing Invested over 60 shares | |
 | Macroaxis Index Invested over 40 shares | |
 | Advertising Invested few shares | |
 | Hedge Favorites Invested over 20 shares | |
 | Investor Favorites Invested few shares | |
 | Software Invested few shares | |
Check out Macroaxis Advice on Opus Genetics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Opus Stock refer to our How to Trade Opus Stock guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Please note, the presentation of Opus Genetics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Opus Genetics' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Opus Genetics' management manipulating its earnings.